Compare NAAS & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NAAS | IMCC |
|---|---|---|
| Founded | 2019 | 1980 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0M | 10.4M |
| IPO Year | 2017 | N/A |
| Metric | NAAS | IMCC |
|---|---|---|
| Price | $3.50 | $1.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.6K | ★ 122.0K |
| Earning Date | 03-31-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $21,817,052.00 | ★ $37,606,703.00 |
| Revenue This Year | $378.49 | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $1.96 | $0.93 |
| 52 Week High | $40.32 | $7.12 |
| Indicator | NAAS | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 49.26 | 53.90 |
| Support Level | $3.31 | $1.54 |
| Resistance Level | $3.89 | $1.84 |
| Average True Range (ATR) | 0.26 | 0.16 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 49.82 | 68.97 |
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.